Revisiting cardiovascular risk reduction in type 2 diabetes and dyslipidemia
{{output}}
Statin therapy has been a mainstay of cardiovascular disease (CVD) risk reduction for the past 20 years in type 2 diabetes management. Its application has been largely due to well-designed, randomized-control studies consistently showing 25-35% CVD risk reduct... ...